Heterogeneity of colorectal carcinoma (CRC) represents a major hurdle towards personalized medicine. Efforts based on whole tumor profiling demonstrated that the CRC molecular subtypes were associated with specific tumor morphological patterns representing tumor subregions. We hypothesize that whole-tumor molecular descriptors depend on the morphological heterogeneity with significant impact on current molecular predictors. We investigated intra-tumor heterogeneity by morphology-guided transcriptomics to better understand the links between gene expression and tumor morphology represented by six morphological patterns (morphotypes): complex tubular, desmoplastic, mucinous, papillary, serrated, and solid/trabecular. Whole-transcriptome profiling by microarrays of 202 tumor regions (morphotypes, tumor-adjacent normal tissue, supportive stroma, and matched whole tumors) from 111 stage II-IV CRCs identified morphotype-specific gene expression profiles and molecular programs and differences in their cellular buildup. The proportion of cell types (fibroblasts, epithelial and immune cells) and differentiation of epithelial cells were the main drivers of the observed disparities with activation of EMT and TNF-α signaling in contrast to MYC and E2F targets signaling, defining major gradients of changes at molecular level. Several gene expression-based (including single-cell) classifiers, prognostic and predictive signatures were examined to study their behavior across morphotypes. Most exhibited important morphotype-dependent variability within same tumor sections, with regional predictions often contradicting the whole-tumor classification. The results show that morphotype-based tumor sampling allows the detection of molecular features that would otherwise be distilled in whole tumor profile, while maintaining histopathology context for their interpretation. This represents a practical approach at improving the reproducibility of expression profiling and, by consequence, of gene-based classifiers.

Berlin Institute of Health Berlin Germany

Central European Institute of Technology Department of Biology Faculty of Medicine Masarykova Univerzita Brno Czech Republic

Central European Institute of Technology Masarykova Univerzita Brno Czech Republic

Department of Pharmacology and Toxicology Faculty of Pharmacy Masarykova Univerzita Brno Czech Republic

Faculty of Medicine Digestive Oncology Unit Katholieke Universiteit Leuven Leuven Belgium

Faculty of Medicine Masarykova Univerzita Brno Czech Republic

German Cancer Research Center Heidelberg Germany

Institute of Pathology Charité Universitätsmedizin Berlin Corporate Member of Freie Universität Berlin Humboldt Universität zu Berlin Berlin Institute of Health Berlin Germany

Masaryk Memorial Cancer Institute Brno Czech Republic

RECETOX Faculty of Science Masarykova Univerzita Brno Czech Republic

Před aktualizací

doi: 10.1101/2023.01.24.525310 PubMed

Před aktualizací

doi: 10.7554/eLife.86655.1 PubMed

Před aktualizací

doi: 10.7554/eLife.86655.2 PubMed

Zobrazit více v PubMed

Amin MB. In: AJCC Cancer Staging Manual. Amin MB, Edge SB, Gress DM, Meyer LR, editors. Chicago IL: Springer; 2017. American Cancer society; pp. XVII–1032.

Betge J, Schneider NI, Harbaum L, Pollheimer MJ, Lindtner RA, Kornprat P, Ebert MP, Langner C. MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance. Virchows Archiv. 2016;469:255–265. doi: 10.1007/s00428-016-1970-5. PubMed DOI PMC

Bosman FT. WHO Classification of Tumours of the Digestive System. Lyon: International Agency for Research on Cancer; 2010.

Budinska E, Popovici V, Tejpar S, D’Ario G, Lapique N, Sikora KO. Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer. The Journal of Pathology. 2013;231:63–76. doi: 10.1002/path.4212. PubMed DOI PMC

Budinska E, Bosman F, Popovici V. Experiments in molecular subtype recognition based on histopathology images. 2016 IEEE 13th International Symposium on Biomedical Imaging; 2016. pp. 1168–1172. DOI

Carvajal LA, Hamard PJ, Tonnessen C, Manfredi JJ. E2F7, a novel target, is up-regulated by p53 and mediates DNA damage-dependent transcriptional repression. Genes & Development. 2012;26:1533–1545. doi: 10.1101/gad.184911.111. PubMed DOI PMC

Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26:2363–2367. doi: 10.1093/bioinformatics/btq431. PubMed DOI PMC

Demirkol S, Gomceli I, Isbilen M, Dayanc BE, Tez M, Bostanci EB, Turhan N, Akoglu M, Ozyerli E, Durdu S, Konu O, Nissan A, Gonen M, Gure AO. A combined ULBP2 and SEMA5A expression signature as a prognostic and predictive Biomarker for Colon Cancer. Journal of Cancer. 2017;8:1113–1122. doi: 10.7150/jca.17872. PubMed DOI PMC

De Palma FDE, D’Argenio V, Pol J, Kroemer G, Maiuri MC, Salvatore F. The Molecular Hallmarks of the serrated pathway in Colorectal Cancer. Cancers. 2019;11:1017. doi: 10.3390/cancers11071017. PubMed DOI PMC

Desbois M, Wang Y. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment. Immunological Reviews. 2021;302:241–258. doi: 10.1111/imr.12982. PubMed DOI

De Sousa E Melo F, Wang X, Jansen M, Fessler E, Trinh A, de Rooij L, de Jong JH, de Boer OJ, van Leersum R, Bijlsma MF, Rodermond H, van der Heijden M, van Noesel CJM, Tuynman JB, Dekker E, Markowetz F, Medema JP, Vermeulen L. Poor-prognosis colon cancer is defined by a molecularly distinct subtype and develops from serrated precursor lesions. Nature Medicine. 2013;19:614–618. doi: 10.1038/nm.3174. PubMed DOI

Dunne PD, McArt DG, Bradley CA, O’Reilly PG, Barrett HL, Cummins R, O’Grady T, Arthur K, Loughrey MB, Allen WL, McDade SS, Waugh DJ, Hamilton PW, Longley DB, Kay EW, Johnston PG, Lawler M, Salto-Tellez M, Van Schaeybroeck S. Challenging the Cancer Molecular Stratification Dogma: Intratumoral Heterogeneity Undermines Consensus Molecular Subtypes and Potential Diagnostic Value in Colorectal Cancer. Clinical Cancer Research. 2016;22:4095–4104. doi: 10.1158/1078-0432.CCR-16-0032. PubMed DOI

Eide PW, Bruun J, Lothe RA, Sveen A. CMScaller: an R package for consensus molecular subtyping of colorectal cancer pre-clinical models. Scientific Reports. 2017;7:16618. doi: 10.1038/s41598-017-16747-x. PubMed DOI PMC

Finotello F, Mayer C, Plattner C, Laschober G, Rieder D, Hackl H, Krogsdam A, Loncova Z, Posch W, Wilflingseder D, Sopper S, Ijsselsteijn M, Brouwer TP, Johnson D, Xu Y, Wang Y, Sanders ME, Estrada MV, Ericsson-Gonzalez P, Charoentong P, Balko J, da Cunha Carvalho de Miranda NF, Trajanoski Z. Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data. Genome Medicine. 2019;11:34. doi: 10.1186/s13073-019-0638-6. PubMed DOI PMC

Gara RK, Kumari S, Ganju A, Yallapu MM, Jaggi M, Chauhan SC. Slit/Robo pathway: a promising therapeutic target for cancer. Drug Discovery Today. 2015;20:156–164. doi: 10.1016/j.drudis.2014.09.008. PubMed DOI PMC

Guinney J, Dienstmann R, Wang X, de Reyniès A, Schlicker A, Soneson C, Marisa L, Roepman P, Nyamundanda G, Angelino P, Bot BM, Morris JS, Simon IM, Gerster S, Fessler E, De Sousa E Melo F, Missiaglia E, Ramay H, Barras D, Homicsko K, Maru D, Manyam GC, Broom B, Boige V, Perez-Villamil B, Laderas T, Salazar R, Gray JW, Hanahan D, Tabernero J, Bernards R, Friend SH, Laurent-Puig P, Medema JP, Sadanandam A, Wessels L, Delorenzi M, Kopetz S, Vermeulen L, Tejpar S. The consensus molecular subtypes of colorectal cancer. Nature Medicine. 2015;21:1350–1356. doi: 10.1038/nm.3967. PubMed DOI PMC

Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7. doi: 10.1186/1471-2105-14-7. PubMed DOI PMC

Hu P, Zhang X, Li Y, Xu L, Qiu H. Pan-Cancer analysis of OLFML2B expression and its association with Prognosis and Immune Infiltration. Frontiers in Genetics. 2022;13:882794. doi: 10.3389/fgene.2022.882794. PubMed DOI PMC

Huber W, Carey VJ, Gentleman R, Anders S, Carlson M, Carvalho BS, Bravo HC, Davis S, Gatto L, Girke T, Gottardo R, Hahne F, Hansen KD, Irizarry RA, Lawrence M, Love MI, MacDonald J, Obenchain V, Oleś AK, Pagès H, Reyes A, Shannon P, Smyth GK, Tenenbaum D, Waldron L, Morgan M. Orchestrating high-throughput genomic analysis with Bioconductor. Nature Methods. 2015;12:115–121. doi: 10.1038/nmeth.3252. PubMed DOI PMC

Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, Mellano A, Senetta R, Cassenti A, Sonetto C, Inghirami G, Trusolino L, Fekete Z, De Ridder M, Cassoni P, Storme G, Bertotti A, Medico E. Stromal contribution to the colorectal cancer transcriptome. Nature Genetics. 2015;47:312–319. doi: 10.1038/ng.3224. PubMed DOI

Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology. 2007;50:113–130. doi: 10.1111/j.1365-2559.2006.02549.x. PubMed DOI

Joanito I, Wirapati P, Zhao N, Nawaz Z, Yeo G, Lee F, Eng CLP, Macalinao DC, Kahraman M, Srinivasan H, Lakshmanan V, Verbandt S, Tsantoulis P, Gunn N, Venkatesh PN, Poh ZW, Nahar R, Oh HLJ, Loo JM, Chia S, Cheow LF, Cheruba E, Wong MT, Kua L, Chua C, Nguyen A, Golovan J, Gan A, Lim WJ, Guo YA, Yap CK, Tay B, Hong Y, Chong DQ, Chok AY, Park WY, Han S, Chang MH, Seow-En I, Fu C, Mathew R, Toh EL, Hong LZ, Skanderup AJ, DasGupta R, Ong CAJ, Lim KH, Tan EKW, Koo SL, Leow WQ, Tejpar S, Prabhakar S, Tan IB. Single-cell and bulk transcriptome sequencing identifies two epithelial tumor cell states and refines the consensus molecular classification of colorectal cancer. Nature Genetics. 2022;54:963–975. doi: 10.1038/s41588-022-01100-4. PubMed DOI PMC

Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118–127. doi: 10.1093/biostatistics/kxj037. PubMed DOI

Kang J, D’Andrea AD, Kozono D. A DNA repair pathway-focused score for prediction of outcomes in ovarian cancer treated with platinum-based chemotherapy. Journal of the National Cancer Institute. 2012a;104:670–681. doi: 10.1093/jnci/djs177. PubMed DOI PMC

Kang HN, Oh SC, Kim JS, Yoo YA. Abrogation of Gli3 expression suppresses the growth of colon cancer cells via activation of p53. Experimental Cell Research. 2012b;318:539–549. doi: 10.1016/j.yexcr.2011.12.010. PubMed DOI

Khaliq AM, Erdogan C, Kurt Z, Turgut SS, Grunvald MW, Rand T, Khare S, Borgia JA, Hayden DM, Pappas SG, Govekar HR, Kam AE, Reiser J, Turaga K, Radovich M, Zang Y, Qiu Y, Liu Y, Fishel ML, Turk A, Gupta V, Al-Sabti R, Subramanian J, Kuzel TM, Sadanandam A, Waldron L, Hussain A, Saleem M, El-Rayes B, Salahudeen AA, Masood A. Refining colorectal cancer classification and clinical stratification through a single-cell atlas. Genome Biology. 2022;23:113. doi: 10.1186/s13059-022-02677-z. PubMed DOI PMC

Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, Lameiras S, Albergante L, Bonneau C, Guyard A, Tarte K, Zinovyev A, Baulande S, Zalcman G, Vincent-Salomon A, Mechta-Grigoriou F. Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer. Cancer Discovery. 2020;10:1330–1351. doi: 10.1158/2159-8290.CD-19-1384. PubMed DOI

Kosinski C, Li VSW, Chan ASY, Zhang J, Ho C, Tsui WY, Chan TL, Mifflin RC, Powell DW, Yuen ST, Leung SY, Chen X. Gene expression patterns of human colon tops and basal crypts and BMP antagonists as intestinal stem cell niche factors. PNAS. 2007;104:15418–15423. doi: 10.1073/pnas.0707210104. PubMed DOI PMC

Lee AM, Shi Q, Pavey E, Alberts SR, Sargent DJ, Sinicrope FA, Berenberg JL, Goldberg RM, Diasio RB. DPYD variants as predictors of 5-fluorouracil toxicity in adjuvant colon cancer treatment (NCCTG N0147) Journal of the National Cancer Institute. 2014;106:dju298. doi: 10.1093/jnci/dju298. PubMed DOI PMC

Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Systems. 2015;1:417–425. doi: 10.1016/j.cels.2015.12.004. PubMed DOI PMC

Liu P, Wang X, Pan L, Han B, He Z. Prognostic significance and immunological role of FBXO5 in Human Cancers: a systematic pan-cancer analysis. Frontiers in Immunology. 2022;13:901784. doi: 10.3389/fimmu.2022.901784. PubMed DOI PMC

Loughrey MB, Fisher NC, McCooey AJ, Dunne PD. Comment on “Identification of EMT-related high-risk stage II colorectal cancer and characterisation of metastasis-related genes. British Journal of Cancer. 2021;124:1175–1176. doi: 10.1038/s41416-020-01213-9. PubMed DOI PMC

Margariti A, Winkler B, Karamariti E, Zampetaki A, Tsai T, Baban D, Ragoussis J, Huang Y, Han J-DJ, Zeng L, Hu Y, Xu Q. Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels. PNAS. 2012;109:13793–13798. doi: 10.1073/pnas.1205526109. PubMed DOI PMC

Marisa L, de Reyniès A, Duval A, Selves J, Gaub MP, Vescovo L, Etienne-Grimaldi MC, Schiappa R, Guenot D, Ayadi M, Kirzin S, Chazal M, Fléjou JF, Benchimol D, Berger A, Lagarde A, Pencreach E, Piard F, Elias D, Parc Y, Olschwang S, Milano G, Laurent-Puig P, Boige V. Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value. PLOS Medicine. 2013;10:e1001453. doi: 10.1371/journal.pmed.1001453. PubMed DOI PMC

Merlos-Suárez A, Barriga FM, Jung P, Iglesias M, Céspedes MV, Rossell D, Sevillano M, Hernando-Momblona X, da Silva-Diz V, Muñoz P, Clevers H, Sancho E, Mangues R, Batlle E. The intestinal stem cell signature identifies colorectal cancer stem cells and predicts disease relapse. Cell Stem Cell. 2011;8:511–524. doi: 10.1016/j.stem.2011.02.020. PubMed DOI

Müller MF, Ibrahim AEK, Arends MJ. Molecular pathological classification of colorectal cancer. Virchows Archiv. 2016;469:125–134. doi: 10.1007/s00428-016-1956-3. PubMed DOI PMC

Muzny DM, Bainbridge MN, Chang K, Dinh HH, Drummond JA, Fowler G. Comprehensive molecular characterization of human colon and rectal cancer. Nature. 2012;487:330–337. doi: 10.1038/nature11252. PubMed DOI PMC

Osmond B, Facey COB, Zhang C, Boman BM. HOXA9 Overexpression Contributes to Stem Cell Overpopulation That Drives Development and Growth of Colorectal Cancer. International Journal of Molecular Sciences. 2022;23:6799. doi: 10.3390/ijms23126799. PubMed DOI PMC

Patel A, Tripathi G, McTernan P, Gopalakrishnan K, Ali O, Spector E, Williams N, Arasaradnam RP. Fibroblast growth factor 7 signalling is disrupted in colorectal cancer and is a potential marker of field cancerisation. Journal of Gastrointestinal Oncology. 2019;10:429–436. doi: 10.21037/jgo.2019.02.11. PubMed DOI PMC

Pelka K, Hofree M, Chen JH, Sarkizova S, Pirl JD, Jorgji V, Bejnood A, Dionne D, Ge WH, Xu KH, Chao SX, Zollinger DR, Lieb DJ, Reeves JW, Fuhrman CA, Hoang ML, Delorey T, Nguyen LT, Waldman J, Klapholz M, Wakiro I, Cohen O, Albers J, Smillie CS, Cuoco MS, Wu J, Su M-J, Yeung J, Vijaykumar B, Magnuson AM, Asinovski N, Moll T, Goder-Reiser MN, Applebaum AS, Brais LK, DelloStritto LK, Denning SL, Phillips ST, Hill EK, Meehan JK, Frederick DT, Sharova T, Kanodia A, Todres EZ, Jané-Valbuena J, Biton M, Izar B, Lambden CD, Clancy TE, Bleday R, Melnitchouk N, Irani J, Kunitake H, Berger DL, Srivastava A, Hornick JL, Ogino S, Rotem A, Vigneau S, Johnson BE, Corcoran RB, Sharpe AH, Kuchroo VK, Ng K, Giannakis M, Nieman LT, Boland GM, Aguirre AJ, Anderson AC, Rozenblatt-Rosen O, Regev A, Hacohen N. Spatially organized multicellular immune hubs in human colorectal cancer. Cell. 2021;184:4734–4752. doi: 10.1016/j.cell.2021.08.003. PubMed DOI PMC

Perez-Villamil B, Romera-Lopez A, Hernandez-Prieto S, Lopez-Campos G, Calles A, Lopez-Asenjo JA, Sanz-Ortega J, Fernandez-Perez C, Sastre J, Alfonso R, Caldes T, Martin-Sanchez F, Diaz-Rubio E. Colon cancer molecular subtypes identified by expression profiling and associated to stroma, mucinous type and different clinical behavior. BMC Cancer. 2012;12:260. doi: 10.1186/1471-2407-12-260. PubMed DOI PMC

Popovici V, Budinská E, Dušek L, Kozubek M, Bosman F. Image-based surrogate biomarkers for molecular subtypes of colorectal cancer. Bioinformatics. 2017;33:2002–2009. doi: 10.1093/bioinformatics/btx027. PubMed DOI

Rao A, Barkley D, França GS, Yanai I. Exploring tissue architecture using spatial transcriptomics. Nature. 2021;596:211–220. doi: 10.1038/s41586-021-03634-9. PubMed DOI PMC

R Development Core Team . Vienna, Austria: R Foundation for Statistical Computing; 2022. https://www.r-project.org

Roepman P, Schlicker A, Tabernero J, Majewski I, Tian S, Moreno V, Snel MH, Chresta CM, Rosenberg R, Nitsche U, Macarulla T, Capella G, Salazar R, Orphanides G, Wessels LFA, Bernards R, Simon IM. Colorectal cancer intrinsic subtypes predict chemotherapy benefit, deficient mismatch repair and epithelial-to-mesenchymal transition. International Journal of Cancer. 2014;134:552–562. doi: 10.1002/ijc.28387. PubMed DOI PMC

Roseweir AK, Park JH, Hoorn ST, Powell AG, Aherne S, Roxburgh CS, McMillan DC, Horgan PG, Ryan E, Sheahan K, Vermeulen L, Paul J, Harkin A, Graham J, Sansom O, Church DN, Tomlinson I, Saunders M, Iveson TJ, Edwards J. Histological phenotypic subtypes predict recurrence risk and response to adjuvant chemotherapy in patients with stage III colorectal cancer. The Journal of Pathology. Clinical Research. 2020;6:283–296. doi: 10.1002/cjp2.171. PubMed DOI PMC

Sadanandam A, Lyssiotis CA, Homicsko K, Collisson EA, Gibb WJ, Wullschleger S, Ostos LCG, Lannon WA, Grotzinger C, Del Rio M, Lhermitte B, Olshen AB, Wiedenmann B, Cantley LC, Gray JW, Hanahan D. A colorectal cancer classification system that associates cellular phenotype and responses to therapy. Nature Medicine. 2013;19:619–625. doi: 10.1038/nm.3175. PubMed DOI PMC

Stewart JP, Richman S, Maughan T, Lawler M, Dunne PD, Salto-Tellez M. Standardising RNA profiling based biomarker application in cancer-The need for robust control of technical variables. Biochimica et Biophysica Acta. Reviews on Cancer. 2017;1868:258–272. doi: 10.1016/j.bbcan.2017.05.005. PubMed DOI

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. PNAS. 2005;102:15545–15550. doi: 10.1073/pnas.0506580102. PubMed DOI PMC

Sun Y, Li M, Liu G, Zhang X, Zhi L, Zhao J, Wang G. The function of Piezo1 in colon cancer metastasis and its potential regulatory mechanism. Journal of Cancer Research and Clinical Oncology. 2020;146:1139–1152. doi: 10.1007/s00432-020-03179-w. PubMed DOI PMC

Tang X, Huang Y, Lei J, Luo H, Zhu X. The single-cell sequencing: new developments and medical applications. Cell & Bioscience. 2019;9:53. doi: 10.1186/s13578-019-0314-y. PubMed DOI PMC

Ten Hoorn S, de Back TR, Sommeijer DW, Vermeulen L. Clinical value of consensus Molecular Subtypes in Colorectal Cancer: a systematic review and meta-analysis. Journal of the National Cancer Institute. 2022;114:503–516. doi: 10.1093/jnci/djab106. PubMed DOI PMC

Ueno H, Ishiguro M, Nakatani E, Ishikawa T, Uetake H, Murotani K, Matsui S, Teramukai S, Sugai T, Ajioka Y, Maruo H, Kotaka M, Tsujie M, Munemoto Y, Yamaguchi T, Kuroda H, Fukunaga M, Tomita N, Sugihara K. Prognostic value of desmoplastic reaction characterisation in stage II colon cancer: prospective validation in a Phase 3 study (SACURA Trial) British Journal of Cancer. 2021;124:1088–1097. doi: 10.1038/s41416-020-01222-8. PubMed DOI PMC

Westrich JA, Vermeer DW, Colbert PL, Spanos WC, Pyeon D. The multifarious roles of the chemokine CXCL14 in cancer progression and immune responses. Molecular Carcinogenesis. 2020;59:794–806. doi: 10.1002/mc.23188. PubMed DOI PMC

Yang M, Li D, Jiang Z, Li C, Ji S, Sun J, Chang Y, Ruan S, Wang Z, Liang R, Dai X, Li B, Zhao H. TGF-β-Induced FLRT3 Attenuation Is Essential for Cancer-Associated Fibroblast-Mediated Epithelial-Mesenchymal Transition in Colorectal Cancer. Molecular Cancer Research. 2022;20:1247–1259. doi: 10.1158/1541-7786.MCR-21-0924. PubMed DOI

Yoshihara K, Shahmoradgoli M, Martínez E, Vegesna R, Kim H, Torres-Garcia W, Treviño V, Shen H, Laird PW, Levine DA, Carter SL, Getz G, Stemke-Hale K, Mills GB, Verhaak RGW. Inferring tumour purity and stromal and immune cell admixture from expression data. Nature Communications. 2013;4:2612. doi: 10.1038/ncomms3612. PubMed DOI PMC

Zhang Q, Zhang C, Ma JX, Ren H, Sun Y, Xu JZ. Circular RNA PIP5K1A promotes colon cancer development through inhibiting miR-1273a. World Journal of Gastroenterology. 2019;25:5300–5309. doi: 10.3748/wjg.v25.i35.5300. PubMed DOI PMC